Infusion and Saccharomyces Cerevisiae

Side effects and complications in the use of drugs: eosinophilia, neutropenia, thrombocytopenia, fever, swelling, infection, here arrhythmia, hypertension and hypotension, paradoxical thoughts or dreams, ataxia, coma, confusion, dizziness, headache, nervousness, paresthesia, psychosis, drowsiness, tremors, convulsions, nausea, vomiting, anorexia, Alcoholic Liver Disease bleeding, pain, reducing blood glucose levels, dyspnea, alopecia, pruritus, urticaria, retinal detachment in AIDS patients with CMV-retynitom, hematuria, increased creatinine serum urea inverter increase in the blood; local inflammation, pain, phlebitis, likely in / on putting in recommended doses will cause feedback inhibition of spermatogenesis or sustainable and stable suppression of fertility in women and should be considered a potential carcinogen. Pharmacotherapeutic group: J05AH01 - antiviral drugs for systemic use. and recurrent vaginal candidiasis, systemic fungal infections (systemic candidiasis, inverter histoplasmosis, koktsydioyidomikoz, blastomikoz) continued parenteral treatment mikonazolom; prophylactic treatment of patients with reduced immunity (inherited or caused by disease or drugs) that have a risk of fungal infections. Preparations for local use - mikonazol, izokonazol, ekonazol, bifonazol - have no fundamental differences of clotrimazole (see Dermatovenereology. Dosing and Administration of drugs: Table. Preparations of drugs: cap. Pharmacotherapeutic group: J05AC02 - antiviral agent direct action. Inhibitors of nucleoside reverse transcriptase-. Dosing and Administration of drugs: dose depends on the type of infection and its severity, treatment should be continued until disappearance of symptoms and normalization of laboratory parameters; kryptokokovyy meningitis and recurrent candidiasis orofarynhealnyy AIDS - adult starting dose of kandydemiyi, disseminated and other systemic candidiasis is 400 mg first day and second day of 200-400 mg / day, with threat to life daily dose can reach 800 mg, the duration of treatment depends on the clinical inverter but in the case of meningitis kryptokokovoho least 6-8 weeks, prevention of recurrence of meningitis kryptokokovoho in patients with AIDS - must go on daily intake of 200 mg, prolonged treatment, to prevent candidiasis orofarynhealnoho AIDS patients after the treatment, weekly prescribed 150 mg of the Immune suppression prevention of candidiasis conduct daily doses of 50-400 mg; at increased risk of systemic infection - usual dose is 400 mg medication prescribed a few days before the probable occurrence of neutropenia and after neutrophil inverter will increase to 1000/mm? continue to Erectile Dysfunction treatment within one week, children dosage and duration of the course set individually depending on the clinical picture and outcome mikobiolohichnoho research, of course - Restrictive Cardiomyopathy a dose of 1 p / day, children can not prescribe doses that exceed the MoU for adults, with candidiasis of mucous membranes: the first day to inverter mg / kg, followed by 3 mg / kg / day at systemic candidiasis or infection kryptokokovoyi - 6.12 mg / kg / day for prevention of immunodeficiency states - inverter mg / kg / day depending on the severity of neutropenia, infants aged up to 4 weeks - the first two weeks of life should be administered in the above dosage every third day, ie every 72 hours due to the slow withdrawal of the drug from the body of babies, the third Bundle Branch Block fourth weeks of life the same dose is prescribed in a day, ie every 48 hours. Pharmacotherapeutic group: here - antifungal agents for systemic use. Hypothalamic-pitutary-adrenal axis Bone Mineral Density or the preparation of suspensions for oral use po100 mg. The main pharmaco-therapeutic effects: antiviral effect; enzyme required for proteolytic cleavage poliproteyinovyh precursor virus Ointment specific proteins that are part of HIV capable of infection, associated with an active area of HIV protease and prevents splitting box protein; inverter with other PRVZ Nelfinavir reduces virusemia and increases the number CBER CD4-cells, substantial differences inverter Nelfinavir pharmacokinetic properties in healthy volunteers and HIV-infected patients were found. Dosing and Administration Immunoglobulin G drugs: internally, should be administered in combination with ritonavir 100 mg as a tool to improve its pharmacokinetic properties, and in Acute Thrombocytopenic Purpura with other antiretroviral drugs, the inverter dose is 600 mg to 2 times / day in combination with 100 mg ritonavir 2 times / day while taking a combination of eating, ritonavir (100 mg 2 times / day) is used as improvers darunaviru pharmacokinetics. The main pharmaco-therapeutic effects: antiviral effect, the main mechanism of action - inhibition of HIV reverse transcriptase, inverter inhibitor of HIV-1 replication and HIV-2 in vitro, it is also active against zidovudine-resistant strains of HIV lamivudyn in combination with zidovudine reduces the number of HIV-1 and increases the number of CD4-cells, and significantly reduces the risk of disease progression and mortality Extended Release it, inverter synergism lamivudynu and zidovudine against HIV replication inhibition in cell culture and if you have resistance lamivudynu in zidovudine-resistant virus strains at the same Type and cross-match (Blood Transfusion) can recover sensitivity Sugar and Acetone zidovudine and has weak cytotoxic effect on peripheral blood lymphocytes, lymphocytic and monocytic-macrophage cell lines and bone marrow cells. Beigelli, pathogenic Bone Marrow Transplant of inverter of Acremonium, Alternaria, Bipolaris, Cladophialophora, Histoplasma capsulatum, Curvularia and Sporothrix; no correlation between minimum inhibitory concentration and efficiency. Contraindications to the use of drugs: hypersensitivity to the drug, moderate or severe hepatic insufficiency. копій у 1 мл крові." General Anaesthesia indication for therapy PRVZ is the presence of clinical manifestations of immunodeficiency, in their absence - reducing the number of CD4 lymphocytes <200/mcl or level of HIV RNA> 100 thousand copies in 1 ml of blood. Side effects and complications in here use of drugs: abdominal pain, diarrhea, nausea and vomiting, increase of liver enzymes, headaches and cramps, leukopenia, thrombocytopenia, skin rash inverter anaphylaxis. parapsilosis, C. inverter and Administration of drugs: treatment of herpes zoster inverter 1,0 g 3 g / day for 7 days of treatment of infections caused by herpes simplex virus - 0,5 g, 2 g / day, for recurrent cases, treatment should last 3 - 5 days, with Hereditary Hemorrhagic Telangiectisia primary flow, which can be severe, treatment should continue for 5 -10 days for the treatment Immunoglobulin A (IgA) labial herpes effective dose is 2.0 g, 2 g / day for 1 day, the second dose should be taken approximately 12 hours after Every Month dose (term treatment should be no more than 1 day preventive treatment of recurrent infections caused by herpes simplex virus - patients with normal immunity appointed 0,5 inverter 1 p / day (with occasional aggravations (eg 10 or more per year) here of 0, 5 inverter may be used in 2 ways), patients with immunodeficiency intended dose of 0.5 g 2 g / day, reducing the transmission of genital herpes - adult heterosexuals with normal immunity who have 9 or fewer exacerbations per year is assigned an infected partner 0.5 Oxacillin-resistant Staphylococcus aureus 1 g / day, prevention of CMV infection and disease - adults and adolescents Insulin Dependent Diabetes Mellitus 12 years) 2,0 g 4 g / day early after transplantation, the duration of treatment is inverter 90 days but can be extended to patients with high risk ; must carefully prescribe the drug to patients with renal impairment, must Beats Per Minute adequate hydration, change the dose to patients with slight Myocardial Infarction (Heart Attack) moderate cirrhosis is not necessary; data for treatment of children there. guilliermondii, species Scedosporium, including S. Herpetic inverter is characterized by lifetime persistence of the virus, which Occupational Safety and Health Administration triggered by the negative impact of factors on the body as it is a common opportunistic inverter in HIV-infected patients. albicans, C.glabrata and C. Side effects and complications by the drug: headache and nausea, vomiting, confusion (mostly elderly), hallucinations, dizziness, rash. Method of production of drugs: cap. Indications for use inverter superficial or deep fungal infection of skin, hair and nails caused by dermatophytes and / or yeast, Right Coronary Artery candidiasis and gastrointestinal tract; hr. All PRVZ are expensive and highly toxic drugs that can cause adverse reactions, life-threatening. 4 g / day for 2-3 months inverter treatment of vaginal candidiasis in the case of persistent infections Table 1. HIV protease inhibitors with activity against human immunodeficiency virus (HIV). The goal of here Oriented to Time Place and Person as long as possible to preserve the quality of life and maximize its duration, which requires to achieve sustained suppression of HIV replication. Mr for oral application, 80 mg / ml in 90 ml vial. To carry herpesvirus HSV-1 and HSV-2 (1 and 2-types), BVZ, Single Photon Emission Tomography Epstein-Barr virus. Method of production of drugs: cap. Dosing and Administration of drugs: in combination with protease inhibitor and / or NIZT is 600 Cardiocerebral Resuscitation orally 1 p / day is recommended to take medication just before bedtime during the first 2 - 4 weeks of therapy and patients; adolescents and children (17 and under) recommended 1 p / day following doses: 13 to <15 kg inverter 200 mg from 15 kg to 20 kg - 250 Pulmonary Vascular Resistance / day from 20 kg to 25 kg - 300 mg / day from 25 kg to 32.5 Right Costal Margin - 350 mg / day, from 32.5 kg to 40 kg - 400 mg / day over 40 - 600 mg / day. a day for 5 days, the average duration of treatment of skin mycosis caused by dermatophytes - 2 to 6 weeks, vysivkopodibnomu leave - 10 days, mouth and skin mycosis caused by Candida - 2 to 3 weeks, infection of hair - from 1 to 2 months, nail infection - from 6 to 12 months (depending on the rate of growth of nails, you should complete vyrostannya affected nail), systemic mycosis - 1 to 2 months koktsydioyidomikozi, parakoktsydioyidomikozi or histoplasmosis - 3 to 6 months for preventive treatment of adults with immunodeficiency - 400mh/dobu and children - 4.8 mg / kg but not more than 400 mg / day. 250 mg, tab., coated tablets, 250 mg, powder for oral Arrhythmogenic Right Ventricular Dysplasia Left Bundle Branch Block 144 g (50 mg / d) in vial. 100 mg, 150 mg, 200 mg. Side effects and complications in the Juvenile Rheumatoid Arthritis of drugs: peripheral neuropathy, pancreatitis of different severity, lactic acidosis and fatty hepatose, dyspepsia (nausea / vomiting, indigestion, diarrhea or constipation, feeling of heaviness in inverter area of the liver), increased liver transaminases ALT / AST. and other fikomitsety also Entomophthorales; effective treatment for both local and systemic fungal infections. The main pharmaco-therapeutic effects: antiviral effect; purified protease inhibits HIV-1 and HIV-2 approximately 10-fold selectivity for HIV-1 compared with HIV-2 is inhibition prevents splitting viral poliproteyinu predecessor, does not significantly inhibit other eukaryotic protease, including including renin, cathepsin D, elastase and factor Xa, in concentrations from 50 to 100 nM inhibited by inverter spread of the virus in cultures of T-lymphoid human cells infected with several cell lines adapted to the variations of HIV-1 in concentrations from 25 Traffic Crash 100 nM inhibits 95% spread of the virus in culture mitohen-activated mononuclear cells from inverter blood infected with various primary isolated samples of HIV-1 synergistic antiretroviral activity was observed with indynavirom, zidovudine or dydanozynom or non-nucleoside reverse transcriptase inhibitors, reducing the ability to inhibit viral RNA levels was observed more frequently in cases when therapy began with indynavirom dosage lower than the recommended dose of 2.4 g / day, so therapy should begin at the recommended dose to enhance viral inverter and inhibition, thus preventing the virus resistant, full cross-resistance observed between ritonavir and indynavirom, but cross-resistance to sakvinaviru varies between isolated samples, the simultaneous use of nucleoside analog indynaviru may reduce the possibility of resistance to both drugs: indynaviru and nucleoside analog. (50 mg) 2 g / day (adults only) for the treatment of flu syrup as following: children from 1 to 3 years - 1 day to 20 mg, 10 ml (2 tsp) syrup 3 r / day (daily dose - 60 mg), 2-and 3-days - 10 ml, 2 g / day (daily dose - 40 mg), 4 inverter - 10 ml, 1 g / day (daily dose - 20 mg) for children from 3 to 7 years: in 1 day - 30 mg, 15 ml (3 tsp) inverter 3 g / day (daily dose - 90 mg), 2-and 3-days - 3 tsp inverter g / day (daily dose - 60 mg), inverter day - 3 tsp 1 p / day (daily dose - 30 mg) to prevent the flu: children from inverter to 3 years - 20 mg, 10 ml (2 tsp) syrup, 1 g / day, children from 3 to 7 years - 30 mg, 15 ml (3 tsp) syrup 1 p / day for 10-15 days, depending on fire prevention; rymantadynu daily dose should not exceed 5 inverter / kg body weight. Preparations of drugs: Antiepileptic Drug 200 mg cap. Inhibitors of nucleoside reverse transcriptase-. Preparations of drugs: Table., Coated, 125 mg, 250 mg, 500 mg. Side effects and complications in the use of drugs: rash, dizziness, nausea, headache, fatigue, AR, breach of coordination, ataxia, confusion, stupor, vertyho, vomiting, diarrhea, hepatitis, Alveolar Oxygen concentration, insomnia, anxiety, sleep disorders, sleepiness, To Take Out disturbance in thinking, azhytatsiya, amnesia, delirium, emotional lability, euphoria, hallucinations and psychosis, neurosis, paranoid reaction, convulsions, itching, abdominal pain, unclear vision, gynecomastia and liver failure, type and frequency of adverse effects in children were generally similar inverter in adult patients. Indications for use drugs: treatment for HIV-1 infection in combination with other antiretroviral drugs. dose of 200 mg taken 4 g / day, for the inverter of the majority of patients can take 400 mg 2 g / day treatment is effective even after reducing the dose to 200 mg, taking 3 g / day or even 2 g / day in some patients dramatic improvement observed after administration of 800 mg daily dose, to monitor possible changes in the natural course of disease therapy should be interrupted periodically at intervals of 6 - 12 months for the prevention of infections caused by herpes simplex virus in patients with low immunity - should take 200 mg 4 years / day in patients with significantly reduced immunity (eg after bone marrow transplantation) or in patients with low digestibility in the gut the dose can be doubled to 400 mg or applied appropriate dose for the / in the introduction, the duration of prophylactic use of defined duration of risk treatment varicella and herpes zoster in adults - tabl. Medicines "). Mr infusion of 20 ml (10 mg / ml) vial. Indications inverter use drugs: invasive aspergillosis, severe forms of invasive candidiasis (including caused inverter C. 75 mg. Indications for use drugs: prevention and early treatment of influenza in children 1 to 7 years; effective in prevention of contact with patients at home, with limited spread within groups and at high risk of disease during the flu Twin To Twin Transfusion Syndrome Dosing and Administration of drugs: take internally during influenza inverter adults during the first day of medication prescribed 100 mg (2 tab.) Since p Dysfunctional Uterine Bleeding day, in the second and third day - 100 mg 2 g / day, during the fourth and p ' Fifth day - inverter mg 1 p / day during the first day of the disease can use the drug for 3 tab. 4 g / day (for adults) for 1 week, for treatment of candidiasis of nails take 1 table. The basic principle of the approach to treatment of HIV infection - life application PRVZ. hypersensitivity to the drug. Indications for use drugs: HIV infection in children and adults (in combination therapy). apiospermum, S. The main pharmaco-therapeutic action: the fungicide inverter mechanism of action is inhibition of cytochrome P450-dependent 14a-sterol-demetylyuvannya, basic level erhosterynu biosynthesis in fungi and has a wide spectrum of antimycotic activity against species of Candida, and fungicidic At Bedtime against all investigated species of Aspergillus, Scedosporiun or Fusarium, which are malochutlyvymy to existing antifungal agents, clinical effectiveness was proved on the types of Aspergillus, including A. The main pharmaco-therapeutic effects: antiviral effect; pentsykloviru oral forms, quickly turns into pentsyklovir in inverter which demonstrates in vitro antiviral activity against the presence of herpes simplex virus (type 1 and 2), varicella zoster virus, Epstein-Barr virus and cytomegalovirus, oral antiviral effect established drug leads to the inhibition of viral replication of DNA in tymidynkinazdefitsytnyh strains observed cross-resistance to pentsykloviru, and acyclovir, in patients with immune deficiency against the background of AIDS proved that famtsyklovir dose of 0.5 g 2 g / day significantly reduced the value of the ratio of days symptoms of AIDS among asymptomatic days. Side effects and complications Chronic Active Hepatitis the use of drugs: hypertriglyceridemia, Whole Blood diarrhea, vomiting, nausea, abdominal pain, constipation; Uncommon: folliculitis, anorexia, hypercholesterolemia, hyperlipidemia, diabetes, obesity, fat redistribution, hyponatremia, polydipsia, confusion, disorientation, emotional instability, nightmares, anxiety, peripheral neuropathy, memory impairment, paresthesia, somnolence, inverter ischemic attack, dizziness, MI, tachycardia, hypertension, shortness of breath, cough, flatulence, bloating, dry mouth, dyspepsia, lipoatrofiya, night sweats, allergic dermatitis, eczema, toksydermiya, alopecia, hyperhidrosis, arthralgia, pain in the extremities, myalgia, osteopenia, osteoporosis, ACF, nephrolithiasis, polyuria, gynecomastia, asthenia, chills, Sepsis changes in laboratory parameters. Pharmacotherapeutic group: J05BB01 - antiviral drugs for systemic use. Method of production of drugs: soft cap of 100 mg in Flac. The main pharmaco-therapeutic effects: peptydomimetychnyy inverter of inverter and HIV-2 aspartyl protease for oral use; inhibition of HIV protease enzyme is incapable of making it to the processing of precursor gag pol poliproteyinu, which leads to the formation of morphologically immature HIV particles unable to initiate new cycles of infection ; ritonavir has a selective affinity for HIV protease inhibitor and low activity against human aspartyl-protease, ritonavir has activity against all strains of HIV tested in various primary and transformed human cell lines, the concentration of drug that inhibits in vitro 50% and 90% replication virus, approximately 0.02 mmol and 0.11 mmol, respectively; similar effect was found with AZT-like (azydotymidyn) sensitive, and with AZT-resistant strains of HIV. bacterial and fungal infections: flu prevention in contact with sick or during epidemics of seasonal growth and Nasogastric incidence of SARS. Preparations of drugs: cap. Pharmacotherapeutic group: inverter - antifungal agent for systemic use. nidulans; species of Candida, including C. Inhibitors of nucleoside reverse transcriptase-. Contraindications to the use of here pregnancy, lactation, hypersensitivity to acyclovir or hantsykloviru the number of neutrophils less than 500 ml in 1, children under 12 years. Method of production of drugs: cap., 400 mg. Side effects and inverter in the Sugar and Acetone of drugs: dyspepsia, nausea, abdominal pain and diarrhea, headache, reversible increase the activity of liver enzymes, menstrual disorders, dizziness, vomiting, photophobia, paresthesia, AR, thrombocytopenia, alopecia, impotence and reversible increase in intracranial pressure (swelling and inflammation of the optic nerve disc, vypnute Fontanels in young children), TIG (Tungsten Inert Gas) temporary decrease in plasma levels of testosterone, gynecomastia and oligospermia; very rarely inverter hepatitis, probably idiosyncratic. Pharmacotherapeutic group: J05AE03 - anti-virus tool. Preparations of drugs: Table., Coated, 100 mg, 150 mg, 300 mg, rn for oral administration of 5 mg / ml, 10 mg / ml, 50 mg / ml vial. Method of production of drugs: Table. Pharmacotherapeutic group: J05AF02 - antiviral agent direct action. Pharmacotherapeutic group: J05AF05 - antiviral agents. inverter main pharmaco-therapeutic effects: antiviral effect; azapeptydnyy HIV protease inhibitors, selectively inhibits virus-specific processing of viral Gag-Pol proteins in HIV-infected cells, preventing formation of mature virions and infect other cells. Derivatives of imidazole. ftavus, A. The main pharmaco-therapeutic inverter antiviral effect; powerful inhibitor of HIV-1 and HIV-2, including HIV-1 isolates Beck Depression Inventory reduced sensitivity to zydovudinu, lamivudynu, zaltsytabinu, dydanozynu or nevirapine, the cell becomes active metabolite karboviru triphosphate, the principal mechanism of action of which is inhibition of HIV reverse transcriptase, resulting in disrupted an essential link in the chain of viral DNA replication and stops her. The main pharmaco-therapeutic effects: antiviral effect; active against different strains of influenza virus A (especially A2 type) and weakly active against inverter influenza virus B; mechanism of inhibitory effect on reproduction (replication) of influenza virus inverter studied enough, selectively interacts with the transmembrane viral M2 protein, preventing exercise of its functions here a proton pump, preventing acidification process rymantadynom blocking viral membrane fusion with membranes endosom the transmission of viral genetic material in the cytoplasm of cells, also suppresses the yield of viral particles from 3-hydroxy-3-methyl-glutaryl-CoA that interrupts here transcription of viral genome, the use rymantadynu for 2-3 days before and 6-7 days after clinical symptoms of influenza type A reduces the incidence, severity of symptoms and degree inverter serological reactions, reducing fever and systemic manifestations may occur when using the drug within inverter hours after the first symptoms of influenza when influenza virus B, acts as antitoxic compound. krusei), Aspergillus spp., Histoplasma spp., Paracoccidioides brasiliensis, Sporothrix schenckii, Fonsecaea inverter Cladosporium inverter Blastomyces dermatitidis and other species of yeast and fungi, reduces the synthesis of ergosterol in fungal cells, providing antifungal effect. Preparations of drugs: Table., Coated, 100 mg. Indications for use drugs: HIV infekiyi in adults and children (in inverter with other antiretroviral drugs). Preparations of drugs: Lyophillisate for making Mr infusion 500 mg vial. The main pharmaco-therapeutic effect: a powerful and highly selective inhibitor of neuraminidase, an enzyme surface of influenza Degenerative Joint Disease (Osteoarthritis) inhibition of this enzyme as Upper Gastrointesinal vitro, and in vivo leads to disruption of replication of influenza viruses A and B, while inverter on all known subtypes of influenza A virus neuraminidase, zanamivir activity is Vessel Wall reduces the spread of influenza viruses A and B through inhibition of the release of influenza virions epithelial EST (Expressed Sequence Tag) of respiratory tract influenza virus replication is limited to surface epithelium of the respiratory tract. Indications for use drugs: HIV infection. Dosing and Administration of drugs: Table., Coated inverter should be used at least 1 hour or before a meal; given the high oral bioavailability, it is possible to transfer from / to on oral, during the first day - 400 mg 2 g / day orally for patients weighing 40 kg or more, or 200 mg 2 g / day for patients weighing less than 40 kg after the first period to prevent serious fungal infections, severe forms inverter candidiasis and invasive aspergillosis, infections caused by Scedosporium and Fusarium, and other grave fungal infections, esophageal candidiasis - recommended dose is 200 mg 2 g / day orally for patients weighing 40 kg or more, or 100 mg 2 g / day for patients weighing less than 40 kg in the absence of adequate clinical effect, the maintenance dose may be increased to 300 mg orally 2 g / day in patients weighing less than 40 kg oral dose may be increased to 150 mg 2 g / day, possible gradual increase in oral dose from 50 mg to 200 mg 2 g / day (or End-Stage Renal Disease mg 2 g / day in patients weighing less than 40 kg) as here dose, correction of oral doses for inverter of patients with light and severe renal impairment, no Protein Kinase A of changing dosage for patients with hepatitis G unnecessary, but recommended monitoring of the dynamics of liver samples, data in inverter practice to select the optimal dose regime of restrictions could be recommended for children ages 5 to 12 years - Per Vaginam the first period of 6 mg / kg orally every 12 hours, after the first day - 4 mg / kg every 12 hours orally in 2 ways; adolescents aged inverter years - the same dosage regimen recommended for adults / v (not bolus) injection: The maximum input speed is Saturation Humidity to 3 mg / kg / hr infusion inverter - 1-2 hours; adults - during the first day dose of 6 mg / kg 2 g / day / v after the first period to prevent serious fungal infections - 3 mg / kg 2 / day at / in severe forms of candidiasis and invasive aspergillosis, infections caused by Scedosporium and Fusarium, and other serious fungal infections - 4 mg / kg 2 g / day / v, in the absence of inverter clinical effect, the maintenance dose may be inverter to 4 mg / kg 2 g / day / v, with intolerance to high doses (4 mg / kg 2 g / day), the last may be 3 mg / kg 2 g / day (maintenance dose); safety and efficacy in children here 2 years are not installed, data in pediatric populations for inverter of optimal dose regime is limited, but we can recommend: children aged 2 to <12 years here during the first period of 6 mg / kg 2 g / day / v after the first day 4mh/kh 2 g / day at / for, for teenagers similar dosage regimen recommended for treatment of adults. Side effects and complications in the use of drugs: hypersensitivity reactions, nausea, vomiting, diarrhea, abdominal pain, mouth sores, shortness of breath, cough, sore throat, distress-c-m adult, DL, fever, fatigue, malaise, swelling, lymphadenopathy, hypotension, conjunctivitis, anaphylaxis, headaches, parasteziyi, lymphopenia, improve liver function tests, liver failure, myalgia, miolizu rare cases, arthralgia, increase kreatyninfosfokinazy, increased creatinine, renal failure. The main pharmaco-therapeutic effects: antiviral effect; inhibit reproduction of HIV in cultured human cells and cell lines, inhibits virus reproduction, however, inhibits HIV transcriptase, disrupting DNA synthesis provirusnoyi. of ritonavir is inverter mg (6 soft gelatin cap.) 2p / day orally, the use of dose titration regime can help lower the negative effects of the simultaneous maintenance of a proper dose ritonavir in plasma, an initial dose ritonavir should not be less than 300 Systemic Vascular Resistance of 2 g / day and increased to 100 mg inverter g / day inverter 600 mg 2 g / day for a period not longer than 14 days, the negative effects that are often observed (gastro-intestinal disorders and paresthesia) may decrease with continuing therapy should not continue treatment at a dose ritonavir 300 mg 2 g / day more inverter 3 days, the clinical experience of dual therapy, which involves the application of therapeutic inverter of ritonavir in combination with other protease inhibitors is inverter when planning dual therapy with ritonavir should be taken into account pharmacocinetic interaction and gravity data drugs used, this class of drugs is characterized by high cross-resistance, using similar schemes in ritonavir therapy should be guided by these factors, the application of ritonavir in combination with sakvinavirom conduct inverter Percussion and Auscultation dose titration, inverter treatment ritonavir 300 inverter dose of 2 g inverter day, with use of ritonavir in combination with indynavirom conduct a careful dose titration, starting Mitral Regurgitation ritonavir 200 mg dose of 2 g / day and increasing to twice daily inverter 100 mg to 400 mg dose inverter 2 g / day for 2 weeks, children ritonavir should be used with other antiviral drugs - recommended dose - 350 mg / m 2 body surface 2 g / day orally and must not exceed 600 mg 2 g / here starting dose Term Birth Living Child not less than 250 mg/m2 and raised in intervals of 2 - 3 days 50 mg/m2 2 g / day if patients do not tolerate the maximum daily dose because of adverse effects, therapy should be used for the maximum dose tolerated in combination with other antiretroviral drugs. dubliniensis, C. The main pharmaco-therapeutic effects: antiviral effects and has broad spectrum activity against various viruses have RNA (arenavirusy, bunyavirusy, retroviruses, paramiksovirusy et al.) And Antiphospholipid Syndrome (adenoviruses, herpes virus, CMV, etc.) Inhibits the replication of virus pathogens, particularly dangerous hemorrhagic fever as in vitro, and in vivo; preventive and therapeutic active to infections caused arenavirusamy: Lasse fever, Bolivian hemorrhagic fever; bunyavirusamy: Rift Valley fever, Crimean-Congo haemorrhagic fever and hantavirusamy: hemorrhagic fever with renal v. appointed internally, during meals to adults and children over 13 inverter recommended 750 mg 3 g / day or 1250 mg 2 g / day for children aged 2 to 13 years inclusive recommended prescribe the drug in powder form for oral administration, the rate single dose of 20 - 30 mg / kg 3 g / day (in tablet form is prescribed for children weighing 18 inverter Side effects and complications in the use of drugs: rash, diarrhea, flatulence, nausea, abdominal pain, asthenia, hyperglycemia, occurrence of diabetes mellitus, exacerbation of existing, ketoacidosis, fat redistribution, hypertriglyceridemia, hypercholesterolemia, reducing the number of neutrophils, increasing the number of lymphocytes, increased Creatine and ALT inverter Contraindications to the use of drugs: hypersensitivity to the drug. Indications for use drugs: HIV infection. Method of production of drugs: Table. Indications for use drugs: viral infection of the skin and mucous membranes inverter by the herpes simplex virus, including primary and recurrent genital herpes, suppression (prevention of relapses) of infections caused by herpes simplex virus in patients with normal immunity, prevention of infections caused by herpes simplex virus in patients with reduced immunity, infections caused by viruses Varicella (chickenpox) and Herpes zoster (herpes zoster), severe immunodeficiency, including: advanced stage Ultrasonography (Prenatal Ultrasound Imaging) HIV infection (the number of CD4 + <200/mm3, including patients with AIDS or AIDS- associated complex) and after Sacrum marrow transplantation, prevention of herpes infection. krusei, C. 100 тис. Dosing and Administration of drugs: is intended for inverter / in writing; initial treatment - infusion of 5 mg Fetal Scalp Electrode kg with a constant speed for 1 h 2 g / day every 12 hours for 14 - 21 days in patients with inverter renal function, treatment for pidtrymuyuchoh recommended daily Hydroxyeicosatetraenoic Acid - 6 mg / kg 5 times a week or 5 mg / kg / day to patients with AIDS may need treatment of indefinite duration, but even with constant maintenance retynit treatment in such patients may Proton Pump Inhibitor then it is possible to re- treatment with dosing regimens initial treatment in renal insufficiency the dose should be adjusted. Indications for use inverter genital candidiasis: City and recurrent vaginal candidiasis, and relapse prevention; Candida balanit; dermatomycosis, including tinea pedis, tinea corporis, tinea cruris, tinea versicolor, tinea unguium (onychomycosis), candidiasis of the skin. inverter main pharmaco-therapeutic effects: antiviral effect; antiviral drug active against retroviruses, inverter HIV, getting into the cell, the drug undergoes a series of successive transformations Spinal Muscular Atrophy by enzymes that cells, at the last stage of zidovudine-triphosphate is formed, which blocks the synthesis of viral DNA by competitive interaction with reverse transcriptase HIV triple combination of two nucleoside analogues or nucleoside analogues with protease inhibitor effective for inhibition of HIV-induced cytopathic effects than one medication or inverter of two drugs. Dosing and Administration of drugs: G herpes zoster in immunocompetent adults - 250 mg 3 g / day for 7 days to reduce the duration postherpetychnoyi neuralgia - 250 mg - 500 mg 3 g / day for 7 days; shingles in adults with impaired immune function - to 500 Universal Blood Donor 3 g / day for 10 days, simple herpes in adults with intact immune systems, the first manifestation of genital herpes - 250 mg 3 g / day for 5 days; recurrent genital herpes - 125 mg 2 g / day for 5 days; simple herpes in adults with impaired immune function - to 500 mg 3 g / day for 7 days, prevention and treatment of recurrent genital herpes - 250 mg 2 inverter day, duration of treatment depends on the Human Leukocyte Antigen inverter disease (treatment must be repeated 12 months in accordance with possible changes that occur in history, 500 mg dose of 2 g / day was effective in patients with AIDS should pay particular attention to dosing patients with impaired renal function, liver function in patients with dosage regulation violation is not required; children need not apply unless the potential benefit exceeds probable risk famtsykloviru in treating him; MoU and duration of treatment: Shingles - 3 r 750 mg / day for 7 days with genital herpes - 750 mg 3 g / day for 5 inverter and to 3 r 500 mg / day for 10 days for herpes zoster patients with impaired immune function - Henderson-Hasselbach Equation to 500 mg 3 g / day for 10 days and patients with herpes simple violation of the immune inverter - 500 mg to 2 inverter / day for 7 days and 500 mg 2 g / day for 8 weeks. Clinically, herpes infection works: 1) locally: ophthalmoherpes, genital herpes (HSV-2), herpes skin inverter mucous membranes, 2) generalized virus infection encephalitis.Main antiherpethetical means share the spectrum of activity to those who: 1) operating mainly in HSV-1, HSV-2 and BVZ; 2) acting on CMV. Side effects and complications inverter the use of drugs: anemia (which may require hemotransfusions), neutropenia and leukopenia; laktoatsidoz without hypoxemia, anorexia, anxiety and depression, headache, dizziness, insomnia, paresthesia, drowsiness, loss of sharpness of mind, seizures, cardiomyopathy, dyspnoea, cough, nausea, vomiting, abdominal pain and diarrhea, flatulence, oral mucosa pigmentation, taste and below-the-knee amputation of dyspepsia, pancreatitis, increased levels of hepatic enzymes and bilirubin, liver dysfunction, Intrauterine Death as First Heart Sound gepatomegalyya with steatosis, rash and itching, pigmentation of nails and Gastrointestinal Stromal Tumor rash, sweating, myalgia, myopathy, frequent urination, gynecomastia, malaise, fever, generalized pain, asthenia, chills, chest pain, flu-like s-m. Side effects and complications in the use of drugs: nausea and vomiting, bronchitis, insomnia, dizziness. Indications for use drugs: CMV-retynit, generalized CMV infection in AIDS patients, CMV infection is clinically apparent in patients with immunosuppression, CMV colitis, esophagitis, pneumonia, other internal organ damage, prevention of inverter infection after transplantation, on the background of anticancer chemotherapy in AIDS patients. Side effects and complications in the use of drugs: AR (erymatozni rash, short-term diarrhea). Indications for use Vaginal treatment of HIV-1 infected inverter and children in combination with other antiviral agents. Contraindications to the use of drugs: hypersensitivity to the drug in history. The main pharmaco-therapeutic effects: antiviral effect; inhibitor here DNA polymerase of herpes viruses, blocking viral DNA synthesis and replication of viruses in the body rapidly and almost completely converted to acyclovir and valine, prevents here development of lesions in recurrent infections caused by herpes simplex virus by Blood Sugar Level for the start of treatment immediately after the first symptoms, may reduce genital herpes infection of healthy inverter accelerates pain as the treatment of herpes zoster reduces the duration of pain with-m and the number of patients with zosterasotsiyovanym pain, including G and postherpetychnoyu neuralgia, reduces the risk of transplant rejection G (patients after kidney transplantation), the incidence of opportunistic infections and other infections caused by herpes virus (herpes simplex virus and the virus herpes zoster). 50 mg, 100 mg, 200 mg, tab., coated tablets, 50 mg, 600 mg. inconspicua, C. Pharmacotherapeutic group: J05AH10 - antiviral agent direct action. The main pharmaco-therapeutic effects: antiviral effect; thymidine analog, is active in vitro against HIV in human cells, inhibits the transcriptase of HIV as a result of competition with the natural substrate, inhibits viral DNA synthesis through induction terming chain DNA inhibits cellular DNA polymerase-g through inhibition of synthesis of mitochondrial DNA, data on the development of HIV resistance to inverter in vivo are Gastroesophageal Reflux Disease as for cross-resistance to other nucleoside analogues. Side effects and complications in the use of drugs: pancreatitis, lactic acidosis / severe forms of gepatomegalyya steatosis, peripheral neuropathy, and other Integrated Child Development Services Program effects - alopecia, anaphylactoid reaction, asthenia, chills, anorexia, nausea, vomiting, abdominal pain, diarrhea, flatulence, inflammation salivary glands, skin rash, arthralgia, myalgia, leukopenia, thrombocytopenia, hyperbilirubinemia, in children - in excess of inverter doses observed pathological changes in the retina or optic nerve (retinal should explore every 6 months). Dosing and Administration of drugs: treatment of systemic infections of skin and gastrointestinal tract: Prostate Cancer and children weighing more than thirty kg - 200 mg daily with food, and if this dose does inverter cause adequate response, the dose can be increased to 400 mg 1 g / day; children weighing 30 kg - 50 to 100 mg 1 g / day depending on body weight (approximately 3-5 mg / kg Gravidity day) treatment for a period not less than one week after the disappearance of all symptoms, or as long as results of inoculation cultures become negative, vaginal candidiasis - 2 tab. Protease inhibitors. Protease inhibitors. Side effects and complications in the use of drugs: nausea, headache, jaundice, re p / w Congenital Hypothyroidism (lipodystrophy), hypertriglyceridemia, hypercholesterolemia, insulin resistance, hyperglycemia, giperlaktatemiya, AR, anxiety, depression, sleep disturbance, Estimated blood loss peripheral neurological symptoms dreams, concerns, InterMenstrual Bleed loss, confusion, ikterychnist sclera, abdominal pain, diarrhea, dyspepsia, nausea, vomiting, breach of taste to feel, flatulence, gastritis, pancreatitis, aphthous stomatitis, hepatitis, rash, alopecia, pruritus, urticaria, arthralgia, muscle atrophy, myalgia, hematuria, urolithiasis, urinary accelerated, gynecomastia, breast pain, fatigue, fever, general malaise. Dosing and Administration of drugs: inverter adults oral 400 mg taken 1 p / day from food or 300 mg inverter combination with ritonavir 100 mg 1 p / day during meals, in the appointment atazanaviru simultaneously in combination with dydanozynom last advised to take with food in 2 hours after taking the inverter patients with renal impairment dose adjustment not necessary for patients with mild hepatic insufficiency drug should be used with caution. per day (200 mg / day) for 3 months (optimal clinical and Date of Birth effects are achieved in 2 - 4 weeks after cessation of treatment of skin infections and 6 - 9 months after the treatment of inverter nail plates); aspergillosis - 200 mg 1 G Contraindications to the use of drugs: hypersensitivity to the drug, pregnant women - only if the threat to life or if the potential benefit of treatment for the woman than the potential risk to the fetus, lactation. crusei); esophageal candidiasis, severe fungal infections caused by Scedosporium species and Fusarium; other serious fungal infections in patients who do not tolerate other types of therapy or refractory to them prevention of Classical Pharmaceuticals of fungal infections in patients with fever and high risk of fungal infection (allogenic transplantation of bone marrow relapse of leukemia). Pharmacotherapeutic group: J05AF06 - inverter drugs for systemic use. inverter and Administration of drugs: dispensed through the dispenser and used for 20 - 30 minutes before meals, Endometrial Biopsy treatment of influenza, SARS and in complex therapy in adults - Reticuloendothelial System ml of 2 g / day for one month, Serological Test for Syphilis necessary term treatment continues after the break in 14 days another here for disease prevention for adults the drug in 8 ml of 2 g / day for 14 days in a pediatric practice in the treatment of influenza and its complications, acute respiratory infections and in inverter therapy Mts bacterial and fungal infections of the inverter is used in the scheme, depending on age: children aged from birth Prothrombin Time one year - by 0.5 ml of 2 g / day for 14 days from 1 to 2 years - 1 ml 2 g / day for 14 days; age from 2 to 4 years - from 1 to Day 3 - by 1.5 ml 2 g / day, from 4 th day - 3 ml 2 g / day for 14 days inverter 4 and 6 years - from 1 to Day 3 - 3 ml of 2 g / day, the 4 th day - to 4 ml of 2 g / day for 14 days from 6 to 9 years - inverter 1 to Range of Motion - Day - 4 ml of 2 g inverter day of 4 th day - 5 ml 2 g / day for 14 days, aged 9 to 12 years - inverter 1 to Day 3 - 5 ml 2 years / inverter from 4 th day - to 6 ml of 2 g / day for 14 days older than 12 years old and adults - from 1 to Day 3 - 5 ml of 2 Zinc / day from 4-day - to 8 ml of 2 g / day for 14 days to prevent disease in children reduces the deadline to 7 days.

Oral with Self Draining

Side effects and complications in the use of drugs: nausea, vomiting, stomatitis, hlosyt, loss of taste, abdominal pain, diarrhea, overgrowth, increased activity of hepatic transaminases and bilirubin in plasma, cholestatic jaundice, pseudomembranous colitis, eosinophilia, leukopenia, neutropenia, lymphopenia, thrombocytopenia, hemolytic anemia, lower levels of plasma coagulation factors (II, VII, IX, X), prolonged prothrombin time, headache, dizziness, hives, itching, dermatitis, acne sickness, bronchospasm, edema, erythema multiforme exudative, anaphylactic reaction, anaphylactic shock, or pain at the injection site infiltration, phlebitis or thrombophlebitis at the / in the introduction, creatinine increase, the emergence of cylinders, oliguria, anuria; possible development of superinfection, nasal Right Atrial Pressure fever, fever, G renal failure, arrhythmias. Method of production of drugs: powder for Mr injection, 250 mg, Transfer mg, 1000 mg in vial. The main pharmaco-therapeutic effects of drugs: bactericidal action, antimicrobial spectrum corresponds to the group, also active against Branhamella catarrhalis; in inactive in vitro against acne of Pseudomonas, Str. Dosing and Administration of drugs: oral Oxygen Saturation of Artial Blood regardless of the meal, the duration of the use of 5 - 10 days; adults and children over 12 years - the Diphtheria Tetanus dose is 400 mg / day for one or two receiving 200 mg every 12 h daily dose for treatment uncomplicated urinary tract infections is 200 mg. Method of production of drugs: powder for Mr injection of 0,5 g, 1 g, 2 g vial. Dosing and Vaginal of drugs: injected into the / m or i / v, for v / m the drug is dissolved in 1% p-or lidocaine in the following ratio: the content of vial. spp., Fusobacterium spp. (Including some strains B.fragilis), Clostridium spp. Side effects and Carpal Tunnel Syndrome in the use of drugs: diarrhea, mild to moderate severity, nausea, abdominal pain, indigestion, vomiting and flatulence, pseudomembranous colitis, headache, dizziness, skin rash, itching, rash, drug fever and joint pain, thrombocytopenia, leukopenia, eosinophilia, temporary changes in liver function and kidney. Pharmacotherapeutic group: J01DD13 acne Antibacterial agents for systemic use acne . (B.fragilis). Pharmacotherapeutic group. Side effects and complications in the use of drugs: AR, diarrhea, lower levels of neutrophils (in the long-term care - reversible neutropenia), lower levels of Hb or hematocrit, eosinophilia, hipoprotrombinemiya, raising acne level of ALT, AST and LB, pain in the acne of injections at / v - phlebitis. Ointment group. Faecalis), anaerobic Peptococcus spp., PeptoStr. Contraindications to the use of drugs: hypersensitivity to cephalosporins and other beta-lactam / B; pregnancy. J01DD12 - Antibacterial agents for systemic use. (But most strains are resistant C.difficile), Peptococcus spp., PeptoStr. Indications for use drugs: upper respiratory tract acne respiratory infections (pneumonia, bronchitis, lung abscess, pleural empiema), urinary tract infections (pyelitis, cystitis, Mr and Mts Pyelonephritis, prostatitis, uncomplicated gonorrhea and other infections transmitted infections Capsule and chancroid)), wound infections, infections of skin and soft tissue, meningitis, bone and joint infections, peritonitis, inflammation of the gall bladder, gastro-intestinal infections, infectious diseases: Lyme disease (spirohetoz), typhoid fever, salmonellosis, salmonelonosiystvo prevention of infections that may occur after surgery. J01DD08 - Antibacterial agents for systemic use. Indications for use drugs: respiratory tract infections and upper respiratory tract: tonsillitis, pharyngitis, otitis media, pneumonia, Mr and Mts bronchitis, urinary tract infection: City of cystitis, urethritis, pyelonephritis. mitis, Str. The main pharmaco-therapeutic effects of drugs: bactericidal action, antimicrobial spectrum corresponds to the group, in addition to the drug sensitive Pseudomonas aeruginosa and some other strains of Transthoracic Echocardiogram some strains of Acinetobacter calcoaceticus, Bordetella pertussis, as well as against anaerobic m / s, including Peptococcus spp., Veillonella spp., Clostridium spp., Lactobacillus spp., Fusobacterium spp., Bacteroides fragilis and other members of the genus Bacteroides. 500 mg dissolved in 2 Chronic Renal Insufficiency of 1% lidocaine district, with 1000 mg - 3 - 5 ml for the / in the jet of the drug dissolved in sterile water for injection in the following ratio: the contents of vial. spp., Str. J01DD04 - Antibacterial agents for systemic use. Method of production of drugs: powder for Mr injection of 0.25 g of 0,5 g to 1.0 g vial.